Pharmascience appoints new VP of operations
by CM Staff
Roger-Ketcha Ngassam will succeed John Primak who is retiring after serving the company as vice president of global operations.
MONTREAL — Pharmascience has announced that Roger-Ketcha Ngassam will join the company as vice president of operation.
Ngassam will succeed John Primak who is retiring after serving the company as vice president of global operations.
Pharmascience says Ngassam will bring more than 20 years of industry knowledge and experience to the company, having worked in sterile and oral solid dosage manufacturing.
He has also held multiple roles at the operational and commercial levels throughout his career.
“The human aspect is paramount in Roger’s eyes, and he makes a point of honour to recognize the impact that people can have on the company. His ability to listen as well as his leadership skills will be a great asset in helping us continue to develop and execute our various operational strategies,” said Jean-Guy Goulet, chief operating officer at Pharmascience in a statement.